Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation and preliminary data from a health-related quality of life questionnaire for owners of dogs with cardiac disease.

Journal of veterinary internal medicine·2020
Same author

Extracellular vesicular microRNAs as potential biomarker for early detection of doxorubicin-induced cardiotoxicity.

Journal of veterinary internal medicine·2020
Same author

Assessment of the responsiveness of the Cats' Assessment Tool for Cardiac Health (CATCH) Questionnaire.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2016
Same author

Pilot study of a myostatin antagonist in dogs with cardiac cachexia.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2015
Same author

Long-term outcome of physiologic VDD pacing versus non-physiologic VVI pacing in dogs with high-grade atrioventricular block.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2015
Same author

What is your diagnosis? Myocardial calcification.

Journal of the American Veterinary Medical Association·2014

Related Experiment Videos

Cardiovascular dysfunction in sepsis and critical illness.

Barret J Bulmer1

  • 1Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, 200 Westboro Road, North Grafton, MA 01536, USA. Barret.Bulmer@tufts.edu

The Veterinary Clinics of North America. Small Animal Practice
|July 16, 2011
PubMed
Summary

Myocardial dysfunction, common in sepsis and critical illness in dogs, increases mortality. Understanding its mechanisms and improving cardiac function management may reduce fatalities.

Related Experiment Videos

Area of Science:

  • Veterinary Medicine
  • Cardiology
  • Critical Care Medicine

Background:

  • Myocardial dysfunction is a frequent complication in human and canine sepsis and critical illness.
  • This cardiac impairment is associated with elevated mortality rates in affected individuals.
  • Effective management requires understanding the underlying disease processes and their impact on the heart.

Purpose of the Study:

  • To review clinical findings, pathophysiologic mechanisms, and current treatment considerations for myocardial dysfunction in critically ill dogs.
  • To highlight the need for further research into identifying and managing cardiac dysfunction in this population.

Main Methods:

  • This review synthesizes existing clinical findings and proposed pathophysiologic mechanisms.
  • It discusses current therapeutic strategies and considerations for myocardial dysfunction.
  • The review emphasizes the need for further research.

Main Results:

  • Myocardial dysfunction is a significant contributor to mortality in sepsis and critical illness.
  • Current understanding of pathophysiologic mechanisms is incomplete.
  • Practical methods for early identification and effective interventions are lacking.

Conclusions:

  • Mitigating the consequences of cardiac impairment requires a thorough understanding of myocardial dysfunction.
  • Further research is essential to develop reliable diagnostic tools and effective, mortality-reducing interventions.
  • Augmenting cardiac performance through timed interventions may reduce mortality in critically ill dogs.